ARCHIVES

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

This article is from The Cancer Letter archive.

Vol. 09 No. 40 | October 21, 1983

Download PDF Visit The Full Archive

Related Articles

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

Cancer Facts & Figures: Cancer Mortality Down 20 Percent Since 1991

January 25, 2013

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992

International Group Plans Survey On Thrombosis Risk

July 27, 2001

Breast Cancer Coalition Plans Petition Urging Comprehensive Strategy

May 14, 1993

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978